Investor Sues Biotech Company Over Alleged COVID-19 Vaccine Misrepresentations
PHILADELPHIA — A pharmaceutical company and its CEO violated federal securities laws after misrepresenting to investors that the company had developed a vaccine for the COVID-19 coronavirus when, in fact, it...To view the full article, register now.
Already a subscriber? Click here to view full article